Biblio

Author Title [ Type(Desc)] Year
Filters: Author is Cui, Jiuwei  [Clear All Filters]
Journal Article
Du Z, Jia L, Wang Y, Wang C, Wen X, Chen J, Zhu Y, Yu D, Zhou L, Chen N, et al. Combined RNA-seq and RAT-seq mapping of long noncoding RNAs in pluripotent reprogramming. Sci Data. 2018;5:180255.
Zhu X, Pan X, Yao L, Li W, Cui J, Wang G, Mrsny RJ, Hoffman AR, Hu J-F. Converting Skin Fibroblasts Into Hepatic-Like Cells by Transient Programming. J Cell Biochem. 2015.
Zhang Y, Hu J-F, Wang H, Cui J, Gao S, Hoffman AR, Li W. CRISPR Cas9-guided chromatin immunoprecipitation identifies miR483 as an epigenetic modulator of IGF2 imprinting in tumors. Oncotarget. 2016.
Li X, Chen N, Zhou L, Wang C, Wen X, Jia L, Cui J, Hoffman AR, Hu J-F, Li W. Erratum: Genome-wide target interactome profiling reveals a novel epigenetic pathway for oncogenic lncRNA in breast cancer. Am J Cancer Res. 2023;13(9):4490-4491.
Zhan X, Guo S, Li Y, Ran H, Huang H, Mi L, Wu J, Wang X, Xiao D, Chen L, et al. Glioma stem-like cells evade interferon suppression through MBD3/NuRD complex-mediated STAT1 downregulation. J Exp Med. 2020;217(5).
Sun L, Feng L, Cui J. Increased expression of claudin-17 promotes a malignant phenotype in hepatocyte via Tyk2/Stat3 signaling and is associated with poor prognosis in patients with hepatocellular carcinoma. Diagn Pathol. 2018;13(1):72.
Wang W, Zhou L, Li H, Sun T, Wen X, Li W, Esteban MA, Hoffman AR, Hu J-F, Cui J. Profiling the role of m6A effectors in the regulation of pluripotent reprogramming. Hum Genomics. 2024;18(1):33.
Liu MM, Ji W, Zhao X, Liu X, Hu J-F, Cui J. Therapeutic potential of engineering the mitochondrial genome. Biochim Biophys Acta Mol Basis Dis. 2023:166804.